Scheid Vineyards Stock Revenue
Scheid Vineyards fundamentals help investors to digest information that contributes to Scheid Vineyards' financial success or failures. It also enables traders to predict the movement of Scheid Pink Sheet. The fundamental analysis module provides a way to measure Scheid Vineyards' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Scheid Vineyards pink sheet.
Scheid |
Scheid Vineyards Company Revenue Analysis
Scheid Vineyards' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Scheid Vineyards Revenue | 72.9 M |
Most of Scheid Vineyards' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scheid Vineyards is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Scheid Vineyards reported 72.9 M of revenue. This is 99.51% lower than that of the Food Products sector and significantly higher than that of the Consumer Staples industry. The revenue for all United States stocks is 99.23% higher than that of the company.
Scheid Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scheid Vineyards' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Scheid Vineyards could also be used in its relative valuation, which is a method of valuing Scheid Vineyards by comparing valuation metrics of similar companies.Scheid Vineyards is currently under evaluation in revenue category among its peers.
Scheid Fundamentals
Profit Margin | (0.03) % | ||||
Operating Margin | (0.02) % | ||||
Current Valuation | 32.88 M | ||||
Shares Owned By Institutions | 1.18 % | ||||
Price To Earning | 1.22 X | ||||
Price To Sales | 0.45 X | ||||
Revenue | 72.9 M | ||||
Gross Profit | 17.77 M | ||||
Net Income | 14.19 M | ||||
Total Debt | 83.6 M | ||||
Earnings Per Share | 15.84 X | ||||
Beta | 0.24 | ||||
Market Capitalization | 32.88 M | ||||
Total Asset | 150.72 M | ||||
Retained Earnings | 27.67 M | ||||
Working Capital | 14.21 M | ||||
Current Asset | 19.41 M | ||||
Current Liabilities | 5.2 M | ||||
Net Asset | 150.72 M |
Pair Trading with Scheid Vineyards
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Scheid Vineyards position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scheid Vineyards will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Beam Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Beam Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Beam Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Beam Therapeutics to buy it.
The correlation of Beam Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Beam Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Beam Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Beam Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Scheid Pink Sheet
If you are still planning to invest in Scheid Vineyards check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scheid Vineyards' history and understand the potential risks before investing.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
CEOs Directory Screen CEOs from public companies around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |